191 related articles for article (PubMed ID: 20713021)
1. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
He L; Shobnam N; Hristova K
Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic activation of receptor tyrosine kinases in mammalian membranes.
He L; Hristova K
J Mol Biol; 2008 Dec; 384(5):1130-42. PubMed ID: 18976668
[TBL] [Abstract][Full Text] [Related]
3. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
4. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
Li E; Hristova K
Cell Adh Migr; 2010; 4(2):249-54. PubMed ID: 20168077
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications.
Iwamoto T; You M; Li E; Spangler J; Tomich JM; Hristova K
Biochim Biophys Acta; 2005 Mar; 1668(2):240-7. PubMed ID: 15737335
[TBL] [Abstract][Full Text] [Related]
7. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
Burke CL; Stern DF
Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
[TBL] [Abstract][Full Text] [Related]
8. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
9. Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.
Bell CA; Tynan JA; Hart KC; Meyer AN; Robertson SC; Donoghue DJ
Mol Biol Cell; 2000 Oct; 11(10):3589-99. PubMed ID: 11029057
[TBL] [Abstract][Full Text] [Related]
10. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
Li E; Hristova K
Biochemistry; 2006 May; 45(20):6241-51. PubMed ID: 16700535
[TBL] [Abstract][Full Text] [Related]
11. Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes.
Placone J; He L; Del Piccolo N; Hristova K
Biochim Biophys Acta; 2014 Sep; 1838(9):2326-30. PubMed ID: 24631664
[TBL] [Abstract][Full Text] [Related]
12. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
13. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.
Matsushita C; Tamagaki H; Miyazawa Y; Aimoto S; Smith SO; Sato T
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1646-51. PubMed ID: 23319611
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.
Hasan M; Patel D; Ellis N; Brown SP; Lewandowski JR; Dixon AM
J Membr Biol; 2019 Oct; 252(4-5):357-369. PubMed ID: 31222471
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.
Sarabipour S; Hristova K
Biophys J; 2013 Jul; 105(1):165-71. PubMed ID: 23823235
[TBL] [Abstract][Full Text] [Related]
18. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
19. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
Peng WC; Lin X; Torres J
Protein Sci; 2009 Feb; 18(2):450-9. PubMed ID: 19165726
[TBL] [Abstract][Full Text] [Related]
20. KIDs rule: regulatory phosphorylation of RTKs.
Locascio LE; Donoghue DJ
Trends Biochem Sci; 2013 Feb; 38(2):75-84. PubMed ID: 23312584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
